Schrödinger Lays Off 60 Staffers Amid Economic Uncertainty

Schrödinger announced it will lay off approximately 60 employees, representing about 7% of its total workforce123.

The layoffs are part of a broader restructuring aimed at reducing costs and boosting company efficiency in response to challenging economic conditions34.

These actions reflect ongoing industry-wide trends as biotech companies seek to conserve cash and adjust operations amid uncertain times34.

Leadership changes accompanied the restructuring, with Richie Jain set to replace Porges in a key role at the company4.

The decision underscores the financial pressures and market headwinds currently affecting the biotech sector4.

Sources:

1. https://firstwordpharma.com/story/5963711

2. https://endpts.com/sv-healths-269m-dementia-fund-schrodinger-lays-off-7-of-staff/

3. https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025

4. https://www.biopharmadive.com/news/tourmaline-pacibekitug-schrodinger-layoffs-crispr-sirius-regenxbio/748562/